FindTrial
Sign In

Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves

Analysis of risk factors for perioperative death in patients undergoing aortic valve replacement using biological valves

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040097
Enrollment
Unknown
Registered
2020-11-21
Start date
2020-11-15
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular heart disease

Interventions

Death group and Survival group:No

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The main arterial valve lesions were diagnosed by echocardiography; 2. Meet with the indications of aortic valve replacement surgery; 3. No life-threatening major diseases; 4. Patients undergoing aortic valve replacement using biological valves; 5. The patients agreed to participate in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete clinical data; 2. In addition to heart disease, patients with end-stage diseases of various organs or patients with other life-threatening diseases; 3. Patients transferred to or discharged from hospital for personal reasons; 4. Patients lost to follow-up; 5. No biological valve was used for aortic valve replacement.

Design outcomes

Primary

MeasureTime frame
Treatment outcome;Operation method;—

Secondary

MeasureTime frame
Basic information of patients;Patients with other chronic diseases;The operation time;—

Countries

China

Contacts

Public ContactXu Liu

Affiliated Hospital of Qingdao University

zbzbzj@163.com+86 19953233323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026